Executives from CG Oncology (NASDAQ:CGON) outlined clinical results, ongoing trials, and launch preparations for its investigational intravesical therapy cretostimogene (referred to as “Credo”) during ...
CG Life, a medical marketing agency focused on rare disease and precision medicine, today launched 24/364, a cultural brand ...
2don MSN
HC Wainwright raises its price target on CG Oncology, Inc. (CGON) to $80 and maintains a buy rating
CG Oncology, Inc. (NASDAQ:CGON) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 27, 2026, H.C. Wainwright raised the firm’s price target on CG Oncology, Inc. (NASDAQ:CGON) to $80 ...
Return on Assets (ROA): CG Oncology's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -6.12%, the company may face hurdles in generating ...
(RTTNews) - CG Oncology Inc. (CGON), a clinical-stage biopharmaceutical company, is making steady progress in the development of its lead investigational oncolytic immunotherapy, Cretostimogene, as ...
The Carlyle Group Inc. (NASDAQ:CG) is one of the dirt cheap stocks to buy now. On February 26, Reuters reported that Carlyle Group announced an ambitious goal to raise $200 billion in new capital by ...
The Carlyle Group Inc. (NASDAQ:CG) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February 24, BofA raised its price recommendation on The Carlyle Group Inc. (NASDAQ:CG) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results